Service Delivery and Patient Outcomes in Ryan White HIV/AIDS Program-Funded and -Nonfunded Health Care Facilities in the United States
Outpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical care and essential support services that help patients remain in care and adhere to treatment. Increased access to Medicaid and private insurance for H...
Gespeichert in:
| Veröffentlicht in: | JAMA internal medicine Jg. 175; H. 10; S. 1650 - 1659 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.10.2015
|
| Schlagworte: | |
| ISSN: | 2168-6114 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Outpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical care and essential support services that help patients remain in care and adhere to treatment. Increased access to Medicaid and private insurance for HIV-infected persons may provide coverage for medical care but not all needed support services and may not supplant the need for RWHAP funding.
To examine differences between RWHAP-funded and non-RWHAP-funded facilities and in patient outcomes between the 2 systems.
The study was conducted from June 1, 2009, to May 31, 2012, using data from the 2009 and 2011 cycles of the Medical Monitoring Project, a national probability sample of 8038 HIV-infected adults receiving medical care at 989 outpatient health care facilities providing HIV medical care.
Data were used to compare patient characteristics, service needs, and access to services at RWHAP-funded vs non-RWHAP-funded facilities. Differences in prescribed antiretroviral treatment and viral suppression were assessed. Data analysis was performed between February 2012 and June 2015.
Overall, 34.4% of facilities received RWHAP funding and 72.8% of patients received care at RWHAP-funded facilities. With results reported as percentage (95% CI), patients attending RWHAP-funded facilities were more likely to be aged 18 to 29 years (8.5% [7.4%-9.5%] vs 5.0% [3.9%-6.2%]), female (29.2% [27.2%-31.2%] vs 20.1% [17.0%-23.1%]), black (47.5% [41.5%-53.5%] vs 25.8% [20.6%-31.0%]) or Hispanic (22.5% [16.4%-28.6%] vs 12.9% [10.6%-15.2%]), have less than a high school education (26.1% [24.0%-28.3%] vs 10.9% [8.7%-13.1%]), income at or below the poverty level (53.6% [50.3%-56.9%] vs 23.9% [19.7%-28.0%]), and lack health care coverage (25.0% [21.9%-28.1%] vs 6.1% [4.1%-8.0%]). The RWHAP-funded facilities were more likely to provide case management (76.1% [69.9%-82.2%] vs 15.4% [10.4%-20.4%]) as well as mental health (64.0% [57.0%-71.0%] vs 18.0% [14.0%-21.9%]), substance abuse (33.6% [27.0%-40.2%] vs 12.0% [8.0%-16.0%]), and other support services; patients attending RWHAP-funded facilities were more likely to receive these services. After adjusting for patient characteristics, the percentage prescribed ART antiretroviral therapy, reported as adjusted prevalence ratio (95% CI), was similar between RWHAP-funded and non-RWHAP-funded facilities (1.01 [0.99-1.03]), but among poor patients, those attending RWHAP-funded facilities were more likely to be virally suppressed (1.09 [1.02-1.16]).
A total of 72.8% of HIV-positive patients received care at RWHAP-funded facilities. Many had multiple social determinants of poor health and used services at RWHAP-funded facilities associated with improved outcomes. Without facilities supported by the RWHAP, these patients may have had reduced access to services elsewhere. Poor patients were more likely to achieve viral suppression if they received care at a RWHAP-funded facility. |
|---|---|
| AbstractList | Outpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical care and essential support services that help patients remain in care and adhere to treatment. Increased access to Medicaid and private insurance for HIV-infected persons may provide coverage for medical care but not all needed support services and may not supplant the need for RWHAP funding.
To examine differences between RWHAP-funded and non-RWHAP-funded facilities and in patient outcomes between the 2 systems.
The study was conducted from June 1, 2009, to May 31, 2012, using data from the 2009 and 2011 cycles of the Medical Monitoring Project, a national probability sample of 8038 HIV-infected adults receiving medical care at 989 outpatient health care facilities providing HIV medical care.
Data were used to compare patient characteristics, service needs, and access to services at RWHAP-funded vs non-RWHAP-funded facilities. Differences in prescribed antiretroviral treatment and viral suppression were assessed. Data analysis was performed between February 2012 and June 2015.
Overall, 34.4% of facilities received RWHAP funding and 72.8% of patients received care at RWHAP-funded facilities. With results reported as percentage (95% CI), patients attending RWHAP-funded facilities were more likely to be aged 18 to 29 years (8.5% [7.4%-9.5%] vs 5.0% [3.9%-6.2%]), female (29.2% [27.2%-31.2%] vs 20.1% [17.0%-23.1%]), black (47.5% [41.5%-53.5%] vs 25.8% [20.6%-31.0%]) or Hispanic (22.5% [16.4%-28.6%] vs 12.9% [10.6%-15.2%]), have less than a high school education (26.1% [24.0%-28.3%] vs 10.9% [8.7%-13.1%]), income at or below the poverty level (53.6% [50.3%-56.9%] vs 23.9% [19.7%-28.0%]), and lack health care coverage (25.0% [21.9%-28.1%] vs 6.1% [4.1%-8.0%]). The RWHAP-funded facilities were more likely to provide case management (76.1% [69.9%-82.2%] vs 15.4% [10.4%-20.4%]) as well as mental health (64.0% [57.0%-71.0%] vs 18.0% [14.0%-21.9%]), substance abuse (33.6% [27.0%-40.2%] vs 12.0% [8.0%-16.0%]), and other support services; patients attending RWHAP-funded facilities were more likely to receive these services. After adjusting for patient characteristics, the percentage prescribed ART antiretroviral therapy, reported as adjusted prevalence ratio (95% CI), was similar between RWHAP-funded and non-RWHAP-funded facilities (1.01 [0.99-1.03]), but among poor patients, those attending RWHAP-funded facilities were more likely to be virally suppressed (1.09 [1.02-1.16]).
A total of 72.8% of HIV-positive patients received care at RWHAP-funded facilities. Many had multiple social determinants of poor health and used services at RWHAP-funded facilities associated with improved outcomes. Without facilities supported by the RWHAP, these patients may have had reduced access to services elsewhere. Poor patients were more likely to achieve viral suppression if they received care at a RWHAP-funded facility. IMPORTANCEOutpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical care and essential support services that help patients remain in care and adhere to treatment. Increased access to Medicaid and private insurance for HIV-infected persons may provide coverage for medical care but not all needed support services and may not supplant the need for RWHAP funding.OBJECTIVETo examine differences between RWHAP-funded and non-RWHAP-funded facilities and in patient outcomes between the 2 systems.DESIGN, SETTING, AND PARTICIPANTSThe study was conducted from June 1, 2009, to May 31, 2012, using data from the 2009 and 2011 cycles of the Medical Monitoring Project, a national probability sample of 8038 HIV-infected adults receiving medical care at 989 outpatient health care facilities providing HIV medical care.MAIN OUTCOMES AND MEASURESData were used to compare patient characteristics, service needs, and access to services at RWHAP-funded vs non-RWHAP-funded facilities. Differences in prescribed antiretroviral treatment and viral suppression were assessed. Data analysis was performed between February 2012 and June 2015.RESULTSOverall, 34.4% of facilities received RWHAP funding and 72.8% of patients received care at RWHAP-funded facilities. With results reported as percentage (95% CI), patients attending RWHAP-funded facilities were more likely to be aged 18 to 29 years (8.5% [7.4%-9.5%] vs 5.0% [3.9%-6.2%]), female (29.2% [27.2%-31.2%] vs 20.1% [17.0%-23.1%]), black (47.5% [41.5%-53.5%] vs 25.8% [20.6%-31.0%]) or Hispanic (22.5% [16.4%-28.6%] vs 12.9% [10.6%-15.2%]), have less than a high school education (26.1% [24.0%-28.3%] vs 10.9% [8.7%-13.1%]), income at or below the poverty level (53.6% [50.3%-56.9%] vs 23.9% [19.7%-28.0%]), and lack health care coverage (25.0% [21.9%-28.1%] vs 6.1% [4.1%-8.0%]). The RWHAP-funded facilities were more likely to provide case management (76.1% [69.9%-82.2%] vs 15.4% [10.4%-20.4%]) as well as mental health (64.0% [57.0%-71.0%] vs 18.0% [14.0%-21.9%]), substance abuse (33.6% [27.0%-40.2%] vs 12.0% [8.0%-16.0%]), and other support services; patients attending RWHAP-funded facilities were more likely to receive these services. After adjusting for patient characteristics, the percentage prescribed ART antiretroviral therapy, reported as adjusted prevalence ratio (95% CI), was similar between RWHAP-funded and non-RWHAP-funded facilities (1.01 [0.99-1.03]), but among poor patients, those attending RWHAP-funded facilities were more likely to be virally suppressed (1.09 [1.02-1.16]).CONCLUSIONS AND RELEVANCEA total of 72.8% of HIV-positive patients received care at RWHAP-funded facilities. Many had multiple social determinants of poor health and used services at RWHAP-funded facilities associated with improved outcomes. Without facilities supported by the RWHAP, these patients may have had reduced access to services elsewhere. Poor patients were more likely to achieve viral suppression if they received care at a RWHAP-funded facility. |
| Author | Frazier, Emma L Dempsey, Antigone Skarbinski, Jacek Hauck, Heather Beer, Linda Weiser, John Patel, Roshni |
| Author_xml | – sequence: 1 givenname: John surname: Weiser fullname: Weiser, John organization: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia – sequence: 2 givenname: Linda surname: Beer fullname: Beer, Linda organization: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia – sequence: 3 givenname: Emma L surname: Frazier fullname: Frazier, Emma L organization: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia – sequence: 4 givenname: Roshni surname: Patel fullname: Patel, Roshni organization: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia2Health Information and Technology Systems, ICF International, Atlanta, Georgia – sequence: 5 givenname: Antigone surname: Dempsey fullname: Dempsey, Antigone organization: HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, Maryland – sequence: 6 givenname: Heather surname: Hauck fullname: Hauck, Heather organization: HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, Maryland – sequence: 7 givenname: Jacek surname: Skarbinski fullname: Skarbinski, Jacek organization: Division of Global HIV/AIDS and Tuberculosis, Centers for Disease Control and Prevention, Atlanta, Georgia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26322677$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kEtOwzAYhC0EogV6BfCSTVq_YjdL1FJaqQJEeSwjJ_5NXSUOOA5SL8C5iaDMZjTSzLeYM3TsGw8IXVEypoTQyU7X2vkIwddgxozQdCxIlh6hIaNymkhKxQCN2nZHek0JEZyfogGTnDGp1BB9byB8uRLwHCr3BWGPtTf4UUcHPuKHLpZNDS12Hj_ttcdvWxcBL1evk5vVfIMfQ_MedJ0sOm_A_E6T-8bbv7gEXcUtnukAeKFLV7me-suKW8AvvkcZvIk6QnuBTqyuWhgd_By9LG6fZ8tk_XC3mt2sEy24jAnPVCEMt4ZIkXFWSGYscDklwgibGWNIyRVAaTJqlFU81VRn6RSKwlqbCsHO0fUf9yM0nx20Ma9dW0JVaQ9N1-ZU0SxTKVG0r14eql3Rf5t_BFfrsM__v2M_BEV1rQ |
| CitedBy_id | crossref_primary_10_1007_s10461_019_02508_6 crossref_primary_10_1097_JNC_0000000000000408 crossref_primary_10_1080_09540121_2018_1545988 crossref_primary_10_1097_JNC_0000000000000249 crossref_primary_10_1521_aeap_2018_30_3_187 crossref_primary_10_2196_56892 crossref_primary_10_1093_cid_ciw442 crossref_primary_10_1007_s10461_016_1345_6 crossref_primary_10_1007_s10461_022_03642_4 crossref_primary_10_1093_cid_ciw280 crossref_primary_10_1097_QAD_0000000000003836 crossref_primary_10_1371_journal_pone_0253444 crossref_primary_10_1097_OLQ_0000000000001680 crossref_primary_10_2196_69842 crossref_primary_10_1097_MEG_0000000000000961 crossref_primary_10_1097_QAI_0000000000001276 crossref_primary_10_1002_cncr_30112 crossref_primary_10_3390_ijerph15112404 crossref_primary_10_1177_00333549221074339 crossref_primary_10_1097_QAI_0000000000002592 crossref_primary_10_1080_09540121_2021_1946001 crossref_primary_10_15585_mmwr_mm7336a1 crossref_primary_10_1080_09540121_2019_1576840 crossref_primary_10_1097_QAI_0000000000003605 crossref_primary_10_1097_QAI_0000000000001702 crossref_primary_10_1089_apc_2017_0125 crossref_primary_10_1093_cid_cix380 crossref_primary_10_1097_QAD_0000000000003565 crossref_primary_10_1097_QAD_0000000000001541 crossref_primary_10_1177_10815589241252592 crossref_primary_10_1080_09540121_2024_2417908 crossref_primary_10_1089_aid_2021_0102 crossref_primary_10_1097_QAI_0000000000001779 crossref_primary_10_1371_journal_pone_0264508 crossref_primary_10_1097_QAD_0000000000000986 crossref_primary_10_1038_srep42637 crossref_primary_10_1080_09540121_2023_2221422 crossref_primary_10_1111_1475_6773_13192 crossref_primary_10_1093_cid_civ708 crossref_primary_10_1097_QAI_0000000000001482 crossref_primary_10_1136_bmjopen_2023_076716 crossref_primary_10_1177_15248399231169924 crossref_primary_10_1257_aer_20220089 crossref_primary_10_1080_09540121_2020_1838428 crossref_primary_10_15585_mmwr_mm6740a2 crossref_primary_10_1089_apc_2022_0065 crossref_primary_10_1080_19419899_2022_2112745 crossref_primary_10_1177_2050312119851006 crossref_primary_10_1097_QAI_0000000000001125 crossref_primary_10_1007_s10461_019_02442_7 crossref_primary_10_1007_s10461_021_03415_5 crossref_primary_10_1001_jamanetworkopen_2019_3822 crossref_primary_10_1093_ofid_ofae284 crossref_primary_10_1089_apc_2020_0202 crossref_primary_10_3390_ijerph17010171 crossref_primary_10_1007_s10461_018_2135_0 crossref_primary_10_7759_cureus_91612 crossref_primary_10_1016_S0140_6736_21_00397_4 crossref_primary_10_2147_HIV_S303791 crossref_primary_10_1016_j_jcpo_2024_100555 crossref_primary_10_1080_09540121_2021_1883512 crossref_primary_10_1097_QAI_0000000000001874 crossref_primary_10_1177_2325957417724204 crossref_primary_10_1007_s40746_019_00155_6 crossref_primary_10_7326_M19_4051 crossref_primary_10_1093_cid_ciw418 crossref_primary_10_1016_j_jacl_2020_11_001 crossref_primary_10_1177_0033354919881438 crossref_primary_10_3390_jof7050369 crossref_primary_10_1016_j_socscimed_2021_114628 crossref_primary_10_1097_JNC_0000000000000314 crossref_primary_10_1177_2325957417729750 crossref_primary_10_2196_52123 crossref_primary_10_2196_15453 crossref_primary_10_1097_QAI_0000000000001987 crossref_primary_10_1002_jia2_25382 crossref_primary_10_1097_QAD_0000000000001068 crossref_primary_10_1097_QAI_0000000000003365 crossref_primary_10_15585_mmwr_mm6537a4 crossref_primary_10_1177_2325957415616491 crossref_primary_10_1016_j_xjep_2022_100514 crossref_primary_10_1097_QAI_0000000000003644 crossref_primary_10_37597_ajphes_2025_31_2_7 crossref_primary_10_1093_ofid_ofy283 crossref_primary_10_1136_jech_2025_223751 crossref_primary_10_1080_09540121_2019_1619660 crossref_primary_10_1080_15381501_2021_1970684 crossref_primary_10_1177_2325957417729754 crossref_primary_10_1097_LGT_0000000000000578 crossref_primary_10_1080_09540121_2022_2121954 crossref_primary_10_1093_ofid_ofy202 crossref_primary_10_1097_JNC_0000000000000224 crossref_primary_10_1097_QAD_0000000000002286 crossref_primary_10_1097_QAI_0000000000002546 crossref_primary_10_1080_09540121_2022_2126960 crossref_primary_10_1093_cid_ciac626 crossref_primary_10_1097_QAI_0000000000002547 crossref_primary_10_1093_cid_ciw834 crossref_primary_10_1097_QAI_0000000000002095 crossref_primary_10_1093_ofid_ofac196 crossref_primary_10_1080_09540121_2020_1738007 crossref_primary_10_1093_cid_ciw278 crossref_primary_10_1371_journal_pone_0234652 crossref_primary_10_1089_apc_2018_0032 crossref_primary_10_1093_cid_ciy571 crossref_primary_10_1093_ofid_ofx003 crossref_primary_10_1007_s10461_025_04865_x crossref_primary_10_1111_jvh_13241 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1001/jamainternmed.2015.4095 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2168-6114 |
| EndPage | 1659 |
| ExternalDocumentID | 26322677 |
| Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: Intramural CDC HHS grantid: CC999999 |
| GroupedDBID | 0R~ 4.4 53G AAGZG AAQQT AARDX AAWTL ABBLC ABJNI ABPMR ACDNT ACGFS ADBBV AENEX AFCHL AHMBA ALMA_UNASSIGNED_HOLDINGS AMJDE ANMPU BRYMA C45 CGR CUY CVF EBD EBS ECM EIF EJD EMOBN EX3 H13 HF~ NPM OB2 OBH OCB OGEVE OHH OVD PQQKQ RAJ SV3 TEORI WH7 WOW YYP ~H1 7X8 |
| ID | FETCH-LOGICAL-a436t-397b4d3fd064932b62dfe36804d4f9ddd0c37eecd91d7f735a1a958ebbfff5442 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 116 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000362594600012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| IngestDate | Mon Jul 21 11:05:54 EDT 2025 Mon Jul 21 05:58:51 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a436t-397b4d3fd064932b62dfe36804d4f9ddd0c37eecd91d7f735a1a958ebbfff5442 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2430794/ioi150068.pdf |
| PMID | 26322677 |
| PQID | 1719975071 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_1719975071 pubmed_primary_26322677 |
| PublicationCentury | 2000 |
| PublicationDate | 2015-10-01 |
| PublicationDateYYYYMMDD | 2015-10-01 |
| PublicationDate_xml | – month: 10 year: 2015 text: 2015-10-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JAMA internal medicine |
| PublicationTitleAlternate | JAMA Intern Med |
| PublicationYear | 2015 |
| References | 26322484 - JAMA Intern Med. 2015 Oct;175(10):1660-1. doi: 10.1001/jamainternmed.2015.4724. |
| References_xml | – reference: 26322484 - JAMA Intern Med. 2015 Oct;175(10):1660-1. doi: 10.1001/jamainternmed.2015.4724. |
| SSID | ssj0000800433 |
| Score | 2.5176044 |
| Snippet | Outpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical care and... IMPORTANCEOutpatient human immunodeficiency virus (HIV) health care facilities receive funding from the Ryan White HIV/AIDS Program (RWHAP) to provide medical... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1650 |
| SubjectTerms | Acquired Immunodeficiency Syndrome - economics Acquired Immunodeficiency Syndrome - epidemiology Acquired Immunodeficiency Syndrome - therapy Adult Ambulatory Care Facilities - economics Ambulatory Care Facilities - statistics & numerical data Anti-Retroviral Agents - therapeutic use Assessment of Medication Adherence Female Financial Management - methods Financial Management - organization & administration HIV Infections - economics HIV Infections - epidemiology HIV Infections - therapy Humans Male Managed Care Programs - statistics & numerical data Middle Aged Needs Assessment Patient Outcome Assessment Program Evaluation Quality Indicators, Health Care Social Support United States - epidemiology |
| Title | Service Delivery and Patient Outcomes in Ryan White HIV/AIDS Program-Funded and -Nonfunded Health Care Facilities in the United States |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/26322677 https://www.proquest.com/docview/1719975071 |
| Volume | 175 |
| WOSCitedRecordID | wos000362594600012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1bS8MwFMeDOhFfvF_mjQi-RrslbdInGc6ygavDG3sbSZNAQbrpNmFfwM_tSdPpkyD4UuhD2pKkye-c_M85CF1woQRggiIys2CgCMsJWLYhEVqpwIINQlkZKHzH01QMBnG_crhNKlnlYk0sF2o9ypyP_KrBnSTC0cv1-I24qlHudLUqobGMahRQxkm6-EB8-1gcDTFKF7KuKtlQXrraYK9xwq7wEgyc8He8LLeZZPO_H7iFNirAxC0_I7bRkil20FqvOkLfRZ_V6oDb5tVpMuZYFhr3fXpVfD-bwtvMBOcFfpjLApcF9HCn-3LV6rYfcd_LuUjiYs902ZSko8L6Wx_ThF1ME05k5mS3uX8WYCb2eIs93u6h5-T26aZDqmIMRDIaTQlwi2KaWg0MA8ynoqa2hkYiYJrZWGsdZJQbk-m4obnlNJQNGYfCKGWtDRlr7qOVYlSYQ4RtECgdKRloKmAPjaUrfwzcZpk2ACS8js4XPTyEye5OMGRhRrPJ8KeP6-jAD9Nw7LNyDF3i-WbE-dEfWh-jdTf2XpR3gmoWfnVzilazj2k-eT8rZxFc037vC-II1Ek |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Service+Delivery+and+Patient+Outcomes+in+Ryan+White+HIV%2FAIDS+Program-Funded+and+-Nonfunded+Health+Care+Facilities+in+the+United+States&rft.jtitle=JAMA+internal+medicine&rft.au=Weiser%2C+John&rft.au=Beer%2C+Linda&rft.au=Frazier%2C+Emma+L&rft.au=Patel%2C+Roshni&rft.date=2015-10-01&rft.eissn=2168-6114&rft.volume=175&rft.issue=10&rft.spage=1650&rft.epage=1659&rft_id=info:doi/10.1001%2Fjamainternmed.2015.4095&rft.externalDBID=NO_FULL_TEXT |